Comparative Pharmacology
Head-to-head clinical analysis: ANADROL 50 versus NANDROLONE PHENPROPIONATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ANADROL 50 versus NANDROLONE PHENPROPIONATE.
ANADROL-50 vs NANDROLONE PHENPROPIONATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Anabolic steroid; binds to androgen receptors, increasing protein synthesis and promoting nitrogen retention, leading to muscle growth and erythropoietin production.
Nandrolone phenpropionate is an anabolic steroid that binds to androgen receptors, activating gene expression leading to increased protein synthesis, nitrogen retention, and muscle growth. It also exhibits weak androgenic activity and may inhibit glucocorticoid receptors.
Adults: 50-200 mg orally once daily for 2-6 weeks, then 2-4 weeks off. Not for continuous use.
100-200 mg intramuscularly every 2-3 weeks.
None Documented
None Documented
Terminal elimination half-life: 4-6 hours for parent drug; active metabolite 17α-methyl-5α-androstan-3α,17β-diol has half-life ~12-18 hours. Requires multiple daily dosing.
Terminal elimination half-life approximately 8-10 hours, but active metabolite 19-nortestosterone has a longer half-life (~2-4 hours), necessitating frequent dosing for stable blood levels.
Primarily renal: 90% as glucuronide and sulfate conjugates; 6% fecal; <3% unchanged.
Primarily renal (90% as metabolites, mainly glucuronide and sulfate conjugates; 6% as unchanged drug); about 4% fecal.
Category C
Category C
Anabolic Steroid
Anabolic Steroid